.

Heron Therapeutics reported $194.21M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
ALKERMES ALKS:US 1.05B 31.16M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Amarin AMRN:US $ 719.12M 53.5M
Ani Pharmaceuticals ANIP:US $ 322.4M 21M
Anika Therapeutics ANIK:US $ 167.86M 2.53M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Eisai 4523:JP Y 620947M 19659M
Emergent Biosolutions EBS:US $ 1084.2M 16.1M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Esperion Therapeutics ESPR:US $ 252.48M 38.34M
GlaxoSmithKline GSK:LN 5418.8B 2520B
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Immunogen IMGN:US $ 373.87M 82.84M
Insmed INSM:US $ 674.73M 81.41M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Ligand Pharmaceuticals LGND:US $ 243.78M 32.28M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Omeros OMER:US $ 192.72M 17.5M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Surmodics SRDX:US $ 60.04M 4.65M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Veracyte VCYT:US $ 235.04M 3.44M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M